Knockdown of the NR4A genes in intratumor Tregs attenuates Treg activity with the decrease of Foxp3 and CTLA-4 and develops effective T helper cell (Th) 1 and CTLs-associated anti-tumor immunity [81]. The gene discussed is FOXP3; the disease is neoplasm.